Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-β, and IL-8

Journal of Artificial Organs

Volumn 11, Issue 4, 2008, Pages 225-231

  Hashimoto, Akiko ^a   Kuroyanagi, Yoshimitsu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Allogeneic cultured dermal substitute; Collagen; Growth factor; Hyaluronic acid

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; INTERLEUKIN 8; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CELL DENSITY; CELL ISOLATION; CELL STRUCTURE; CRYOPRESERVATION; CULTURE MEDIUM; CULTURED DERMAL SUBSTITUTE; CYTOKINE RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INFANT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN ALLOGRAFT; STANDARDIZATION; TISSUE ENGINEERING;

CELL COUNT; CULTURE TECHNIQUES; CYTOKINES; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT; INTERLEUKIN-8; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 59449098673     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-008-0436-1     Document Type: Article

References (23)

1. T.B. Boyce 2001 Design principles for composition and performance of cultured skin substitutes Burns 27 523 533
2. K. Kubo Y. Kuroyanagi 2003 Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: fundamental evaluation J Biomater Sci Polymer Edn 14 625 641
3. K. Kubo Y. Kuroyanagi 2003 Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test J Artif Organs 6 64 70
4. K. Kubo Y. Kuroyanagi 2003 Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts J Artif Organs 6 138 144
5. K. Kubo Y. Kuroyanagi 2003 Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro J Artif Organs 6 267 272
6. Y. Kuroyanagi K. Kubo H. Matsui H.J. Kim S. Numari Y. Mabuchi S. Kagawa 2004 Establishment of banking system for allogeneic cultured dermal substitute Artif Organs 28 13 21
7. K. Kubo Y. Kuroyanagi 2004 Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: cryopreservation Artif Organs 28 182 188
8. K. Kubo Y. Kuroyanagi 2005 The possibility of long-term cryopreservation of cultured dermal subsitute Artif Organs 29 800 805
9. K. Kubo Y. Kuroyanagi 2005 A study of cytokines released from fibroblasts in cultured dermal subsitute Artif Organs 29 845 849
10. N. Kashiwa O. Ito T. Ueda K. Kubo H. Matsui Y. Kuroyanagi 2004 Treatment of full-thickness skin defect with concomitant grafting of sixfold extended mesh auto-skin and allogeneic cultured dermal substitute Artif Organs 28 444 450
11. T. Ohtani K. Okamoto C. Kaminaka T. Kishi M. Sakurane Y. Yamamoto K. Ueda K. Kubo Y. Kuroyanagi F. Furukawa 2004 Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS) Eur J Dermatol 14 168 171
12. Y. Moroi S. Fujita S. Fukagawa T. Mashino T. Goto T. Masuda K. Urabe K. Kubo H. Matsui S. Kagawa Y. Kuroyanagi M. Furue 2004 Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection Eur J Dermatol 14 172 176
13. T. Hasegawa Y. Suga M. Mizoguchi S. Ikeda H. Ogawa K. Kubo H. Matsui S. Kagawa Y. Kuroyanagi 2004 Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa J Am Acad Dermatol 50 803 804
14. T. Hasegawa Y. Suga M. Mizoguchi S. Muramatsu Y. Minuzo H. Ogawa K. Kubo Y. Kuroyanagi 2005 An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports J Dermatol 32 715 720
15. T. Hasegawa Y. Suga M. Mizoguchi S. Muramatsu Y. Mizuno S. Ikeda K. Haruna Y. Kuroyanagi H. Ogawa 2007 A case of intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute Scand J Plast Reconstr Surg Hand Surg 41 326 328
16. M. Yonezawa H. Tanizaki N. Inoguchi M. Ishida M. Katoh T. Tachibana Y. Miyachi K. Kubo Y. Kuroyanagi 2007 Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers Int J Dermatol 46 36 42
17. J. Nishimoto Y. Amoh K. Tanabe N. Niiyama K. Katsuoka Y. Kuroyanagi 2007 Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute Eur J Dermatol 17 350 351
18. P. Dijke K.K. Iwata 1989 Growth factors for wound healing Biotechnology 7 793 798
19. V. Falanga 1993 Growth factors and wound healing J Dermatol Surg Oncol 19 711 714
20. V. Moulin 1995 Growth factor in skin wound healing Eur J Cell Biology 68 1 7
21. N.N. Nissen P.J. Polverini A.E. Koch M.V. Volin R.L. Gamelli L.A. DiPietro 1998 Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing Am J Pathol 152 1445 1452
22. C.J. Corral A. Siddiqui L. Wu C.L. Farrell D. Lyons T.A. Mustoe 1999 Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing Arch Surg 134 200 205
23. F. Nayeri T. Stromberg M. Larsson L. Brudin C. Soderstrom P. Forsberg 2002 Hepatocyte growth factor may accelerate healing in chronic leg ulcers: pilot study J Dermatol Treat 13 81 86